CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Kevin Lobo

Chairman, Chief Executive Officer & President, Stryker Corporation

Search every verified Kevin Lobo interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Kevin Lobo, Chair and CEO of Stryker, participated in a keynote conversation with Matthew P. Abdel, M.D., Chair of the Surgical and Procedural Practice at Mayo Clinic, at the LSI Europe '26 Emerging Medtech Summit in Barcelona. During the discussion, Lobo addressed Stryker's growth and culture, noting that the company's mission and values are reinforced through consistent communication. He described his leadership approach as one that empowers division presidents to make informed decisions and take risks, stating that he does not "take their head off" if a risk does not work out, as long as the overall decision-making record is strong. Lobo also discussed Stryker's strategic focus, saying the company leverages its strengths in innovation and customer intimacy across areas such as peripheral vascular and neurovascular, applying the same formula used in orthopedics and trauma. He stated that Stryker is not attempting to be "everything to everybody," citing no plans to enter diabetes or diagnostics. On technology, Lobo expressed optimism about artificial intelligence, suggesting that AI could bring "science to healthcare" by providing surgeons with insights from aggregated procedural data, using Stryker's Mako robotic system as an example of a future "intelligent partner" for surgeons.

Recent appearances

Notable quotes

“I just look at our company and say what are our strengths? Our strengths are innovation. Our strengths are intimacy with the customer and we want to solve customer problems and but that can work in peripheral vascular in neurovascular. It's the same formula. It's the same formula that works in orthopedics and trauma. And so I just believe it's very translatable. Now we're not trying to be everything to everybody. So ”

“I'm very bullish on AI and the ability for AI, frankly, to bring science to healthcare. So, I'll give you a simple example. If I go to see you for a hip and knee replacement, I'm getting your lived experience, where you went to school, where you did your training, what procedures you've done. Whereas if you use Mako with AI in the future, that's going to be an intelligent partner to you're going to get the lived expe”

“If we're wrong, it's not gonna kill the company. We have such a strong balance sheet, we could afford to make a $1.6 billion bet. ... That's if we're wrong, if we're right, this has an asymmetric upside, we will be right for a decade if we're right and that first mover advantage is gonna be significant.”

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →